Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus

Transplantation Proceedings

Volumn 35, Issue 5, 2003, Pages 1877-1879

  Herrero, J Ignacio ^a   Quiroga, J ^a   Sangro, B ^a   Pardo, F ^a   Rotellar, F ^a   Cienfuegos, J A ^a   Prieto, J ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CALCINEURIN INHIBITOR; CYCLOSPORIN; HEMOGLOBIN A1C; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; UREA; URIC ACID;

ACUTE GRAFT REJECTION; ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; DIABETES MELLITUS; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG SAFETY; DRUG SCREENING; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; GLUCOSE METABOLISM; HUMAN; LIVER TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECIPIENT; SURGICAL PATIENT; TREATMENT OUTCOME; UREA BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 0042833202     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00644-4     Document Type: Conference Paper

References (12)

1. Blanco J.J., Herrero J.I., Quiroga J., et al. Liver Transpl. 7:2001;226.
2. Navasa M., Bustamante J., Marroni C., et al. J Hepatol. 25:1996;64.
3. Shields P.L., Tang H., Neuberger J.M., et al. Transplantation. 68:1999;530.
4. Trail K.C., Stratta R.J., Larsen J.L., et al. Surgery. 114:1993;650.
5. Wahlstrom H.E., Cooper J., Gores G., et al. Transplant Proc. 23:1991;1565.
6. Zein N.N., Abdulkarim A.S., Wiesner R.H., et al. J Hepatol. 32:2000;209.
7. Bigam D.L., Pennington J.J., Carpentier A., et al. Hepatology. 32:2000;87.
8. Pruthi J., Medkiff K.A., Esrason K.T., et al. Liver Transpl. 7:2001;811.
9. Reisaeter A.V., Hartmann A. Transplant Proc. 33:2001;8S.
10. Herrero J.I., Quiroga J., Sangro B., et al. Liver Transpl Surg. 5:1999;414.
11. Schlitt H.J., Barkmann A., Böker K.H.W., et al. Lancet. 357:2001;587.
12. Stewart S.F., Hudson M., Talbot D., et al. Lancet. 357:2001;609.